{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:08:26Z","timestamp":1780697306658,"version":"3.54.1"},"reference-count":24,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["66691"],"award-info":[{"award-number":["66691"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["NCL2Treat"],"award-info":[{"award-number":["NCL2Treat"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>Late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) is a neurodegenerative, blinding lysosomal storage disorder. The purpose of the current study was to characterise the progression of CLN2-associated retinal degeneration in patients under intraventricular enzyme replacement therapy (ERT) with cerliponase alfa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analysed visual function, retinal morphology and neuropaediatric data using preferential looking test (PLT), Weill Cornell Batten Scale (WCBS), optical coherence tomography (OCT) imaging and the Hamburg Motor-Language late-infantile neuronal ceroid lipofuscinosis (LINCL) Scale (M-L scale).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-six eyes of 28 patients had baseline PLT, WCBS and OCT. 15 patients underwent serial examinations, resulting in a total of 132 OCT scans and WCBS results, 66 Hamburg M-L scores and 49 PLT results during a mean follow-up time of 18.2 months (range 5\u201340). A negative correlation (r=\u20130.69, p&lt;0.001) was found between central retinal thickness (CRT) values and age at examination with a maximal annual decrease of 23\u2009\u00b5m between 56 and 80 months of age. A significant correlation was observed between PLT results and the age at examination (r=0.46, p=0.001), the WCBS scores (r=0.62; p&lt;0.001) and CRT values (r=\u20130.64; p&lt;0.001). The M-L score correlated with the ocular measurements (CRT: r=0.58, p&lt;0.001; WCBS r=\u22120.64, p&lt;0.001; PLT score: r=\u22120.57, p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite intraventricular ERT, retinal degeneration progressed in patients with CLN2 and was particularly pronounced between 56 and 80 months of age. Retina-directed therapies should therefore be initiated before or as early as possible during the phase of rapid retinal degeneration. PLT and WCBS were identified as valuable outcome measures to monitor disease progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04613089\">NCT04613089<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjo-2022-321260","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:54:26Z","timestamp":1656611666000},"page":"1478-1483","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)"],"prefix":"10.1136","volume":"107","clinical-trial-number":[{"clinical-trial-number":"nct04613089","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6893-9714","authenticated-orcid":false,"given":"Simon","family":"Dulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Schwering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Spartalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schuettauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wibbeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Stephan","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniya","family":"Atiskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"2023092102150603000_107.10.1478.1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2023092102150603000_107.10.1478.2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10660"},{"key":"2023092102150603000_107.10.1478.3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.oret.2020.01.011","article-title":"Symmetric age association of retinal degeneration in patients with CLN2-Associated Batten disease","volume":"4","author":"Kovacs","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"2023092102150603000_107.10.1478.4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/eye.1998.148","article-title":"The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses","volume":"12 (Pt 3b","author":"Weleber","year":"1998","journal-title":"Eye"},{"key":"2023092102150603000_107.10.1478.5","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.1.23"},{"key":"2023092102150603000_107.10.1478.6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073128"},{"key":"2023092102150603000_107.10.1478.7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10633-021-09825-z","article-title":"Evolution of the retinal function by flash-ERG in one child suffering from neuronal ceroid lipofuscinosis CLN2 treated with\u00a0cerliponase alpha: case report","volume":"143","author":"Rigaudi\u00e8re","year":"2021","journal-title":"Doc Ophthalmol"},{"key":"2023092102150603000_107.10.1478.8","doi-asserted-by":"crossref","unstructured":"Thompson DA , Handley SE , Henderson RH . An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy. Eye 2021.","DOI":"10.1038\/s41433-021-01720-w"},{"key":"2023092102150603000_107.10.1478.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712649"},{"key":"2023092102150603000_107.10.1478.10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","article-title":"Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Whiting","year":"2013","journal-title":"Exp Eye Res"},{"key":"2023092102150603000_107.10.1478.11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","article-title":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","volume":"146","author":"Whiting","year":"2016","journal-title":"Exp Eye Res"},{"key":"2023092102150603000_107.10.1478.12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5413","article-title":"Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2","volume":"12","author":"Sondhi","year":"2020","journal-title":"Sci Transl Med"},{"key":"2023092102150603000_107.10.1478.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108135","article-title":"Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis","volume":"198","author":"Whiting","year":"2020","journal-title":"Exp Eye Res"},{"key":"2023092102150603000_107.10.1478.14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exer.2016.09.003","article-title":"Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis","volume":"152","author":"Tracy","year":"2016","journal-title":"Exp Eye Res"},{"key":"2023092102150603000_107.10.1478.15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20608"},{"key":"2023092102150603000_107.10.1478.16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/cge.13673","article-title":"Functional characterization of novel MFSD8 pathogenic variants anticipates neurological involvement in juvenile isolated maculopathy","volume":"97","author":"Bauwens","year":"2020","journal-title":"Clin Genet"},{"key":"2023092102150603000_107.10.1478.17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10633-018-9665-7","article-title":"Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3)","volume":"138","author":"Chen","year":"2019","journal-title":"Doc Ophthalmol"},{"key":"2023092102150603000_107.10.1478.18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jmd2.12097","article-title":"The c.1A\u2009>\u2009C start codon mutation in CLN3 is associated with a protracted disease course","volume":"52","author":"Kuper","year":"2020","journal-title":"JIMD Rep"},{"key":"2023092102150603000_107.10.1478.19","first-page":"87","article-title":"Visual acuity in the first two years of life in healthy term newborns: an experience with the Teller acuity cards","volume":"17","author":"Cavallini","year":"2002","journal-title":"Funct Neurol"},{"key":"2023092102150603000_107.10.1478.20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/eye.1989.127","article-title":"Preferential looking in the mentally handicapped","volume":"3(Pt 6)","author":"Chandna","year":"1989","journal-title":"Eye"},{"key":"2023092102150603000_107.10.1478.21","first-page":"2572","article-title":"Grating visual acuity using the preferential-looking method in elderly nursing home residents","volume":"43","author":"Friedman","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023092102150603000_107.10.1478.22","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0042-6989(97)00098-9","article-title":"Hidden visual capabilities in mentally retarded subjects diagnosed as deaf-blind","volume":"37","author":"Jacobsen","year":"1997","journal-title":"Vision Res"},{"key":"2023092102150603000_107.10.1478.23","doi-asserted-by":"publisher","DOI":"10.1076\/stra.7.1.1.656"},{"key":"2023092102150603000_107.10.1478.24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1469-8749.1996.tb15083.x","article-title":"Vision, cognition and developmental characteristics of girls and women with Rett syndrome","volume":"38","author":"von Tetzchner","year":"1996","journal-title":"Dev Med Child Neurol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2022-321260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T09:19:38Z","timestamp":1695287978000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2022-321260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bjo-2022-321260"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2022-321260","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}